Effects of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism

NCT01057732 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2010-01-27

No results posted yet for this study

Summary

Primary hyperparathyroidism (PHPT) is associated with increased cardiovascular morbidity. The benefit of surgical treatment in this respect is unclear.

This study was performed to evaluate the impact of parathyroidectomy (PTX) on cardiovascular risk profile.

Conditions

  • Primary Hyperparathyroidism

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2006-06-30
Completion
2006-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01057732 on ClinicalTrials.gov